Crossing Kingdoms: Host-Microbial Endotyping and the Quest to Understand Treatable Traits in Chronic Obstructive Pulmonary Disease.
作者信息
Segal Leopoldo N, Huang Yvonne J
机构信息
Division of Pulmonary, Critical Care, and Sleep Medicine New York University School of Medicine, New York New York.
Division of Pulmonary and Critical Care Medicine University of Michigan Ann Arbor, Michigan.
出版信息
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1447-1448. doi: 10.1164/rccm.202101-0169ED.
Abstract
摘要
相似文献
1
Crossing Kingdoms: Host-Microbial Endotyping and the Quest to Understand Treatable Traits in Chronic Obstructive Pulmonary Disease.跨越王国：宿主-微生物分型与理解慢性阻塞性肺疾病可治疗特征的探索
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1447-1448. doi: 10.1164/rccm.202101-0169ED.
2
Asthma and COPD "overlap": a treatable trait or common several treatable-traits?哮喘和 COPD“重叠”：一种可治疗的特征还是常见的多种可治疗特征？
Eur Ann Allergy Clin Immunol. 2020 Jul 2;52(4):148-159. doi: 10.23822/EurAnnACI.1764-1489.138.
3
Triaging treatable traits in asthma.
Respirology. 2019 Jan;24(1):5-6. doi: 10.1111/resp.13406. Epub 2018 Sep 19.
4
Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.慢性阻塞性肺疾病 - 稳定期疾病的诊断和管理；基于临床表型的可治疗特征概念，采用个体化护理方法。捷克肺病和结核学会立场文件。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Dec;164(4):325-356. doi: 10.5507/bp.2020.056.
5
Adding some NOVELTY to treatable traits.为可治疗的特征增添一些新颖性。
Respirology. 2022 Nov;27(11):912-913. doi: 10.1111/resp.14341. Epub 2022 Aug 4.
6
Treatable traits of chronic airways disease.慢性气道疾病的可治疗特征。
Curr Opin Pulm Med. 2018 Jan;24(1):24-31. doi: 10.1097/MCP.0000000000000445.
7
Breathomics and treatable traits for chronic airway diseases.呼吸组学与慢性气道疾病的可治疗特征。
Curr Opin Pulm Med. 2019 Jan;25(1):94-100. doi: 10.1097/MCP.0000000000000534.
8
Precision medicine and treatable traits in chronic airway diseases - where do we stand?精准医学与慢性气道疾病的可治疗特征 - 我们处于什么位置？
Curr Opin Pulm Med. 2020 Jan;26(1):33-39. doi: 10.1097/MCP.0000000000000639.
9
Treatable traits in asthma: moving beyond diagnostic labels.哮喘的可治疗特征：超越诊断标签
Med J Aust. 2022 Apr 18;216(7):331-333. doi: 10.5694/mja2.51464. Epub 2022 Mar 28.
10
Is the Social Component of chronic obstructive pulmonary disease a Treatable Trait?慢性阻塞性肺疾病的社会因素是一种可治疗的特征吗？
Arch Bronconeumol (Engl Ed). 2020 Apr;56(4):199-200. doi: 10.1016/j.arbres.2019.06.019. Epub 2019 Jul 24.
引用本文的文献
1
Toward precision medicine in COPD: phenotypes, endotypes, biomarkers, and treatable traits.迈向慢性阻塞性肺疾病的精准医学：表型、内型、生物标志物和可治疗特征。
Respir Res. 2025 Sep 29;26(1):274. doi: 10.1186/s12931-025-03356-w.
2
Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?可治疗的特征可否作为解决 COPD 复杂性和异质性的方法？
Int J Chron Obstruct Pulmon Dis. 2023 Sep 8;18:1959-1964. doi: 10.2147/COPD.S428391. eCollection 2023.
3
Inhaled Antibiotics and Airway Bacterial Decolonization for Patients with Chronic Obstructive Pulmonary Disease: The Rationale and Future.吸入性抗生素与慢性阻塞性肺疾病患者的气道细菌去定植：理论依据与未来展望。
J Transl Int Med. 2022 May 4;10(3):181-184. doi: 10.2478/jtim-2022-0005. eCollection 2022 Sep.
本文引用的文献
1
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.慢性阻塞性肺疾病临床稳定期和加重期的炎症表型相关气道微生物组：一项多队列纵向分析。
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1488-1502. doi: 10.1164/rccm.202009-3448OC.
2
Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma.痰和口腔微生物群与轻度哮喘的特应性、免疫学和临床特征的不同关联。
J Allergy Clin Immunol. 2020 Nov;146(5):1016-1026. doi: 10.1016/j.jaci.2020.03.028. Epub 2020 Apr 13.
3
Methods in Lung Microbiome Research.肺微生物组研究方法。
Am J Respir Cell Mol Biol. 2020 Mar;62(3):283-299. doi: 10.1165/rcmb.2019-0273TR.
4
Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.囊性纤维化气道微生物组在临床稳定期的测量。
Ann Am Thorac Soc. 2019 Dec;16(12):1534-1542. doi: 10.1513/AnnalsATS.201903-270OC.
5
Inflammatory endotypes in COPD.COPD 的炎症内型。
Allergy. 2019 Jul;74(7):1249-1256. doi: 10.1111/all.13760. Epub 2019 Mar 31.
6
Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation.慢性阻塞性肺疾病生物标志物及其解读。
Am J Respir Crit Care Med. 2019 May 15;199(10):1195-1204. doi: 10.1164/rccm.201810-1860SO.
7
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials.慢性阻塞性肺疾病患者加重风险和布地奈德治疗反应的预测因素：三项随机试验的事后分析。
Lancet Respir Med. 2018 Feb;6(2):117-126. doi: 10.1016/S2213-2600(18)30006-7. Epub 2018 Jan 10.
8
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.痰和血嗜酸性粒细胞浓度与 COPD 严重程度的临床指标的关联：SPIROMICS 队列分析。
Lancet Respir Med. 2017 Dec;5(12):956-967. doi: 10.1016/S2213-2600(17)30432-0. Epub 2017 Nov 13.
9
Airway Mucin Concentration as a Marker of Chronic Bronchitis.气道黏液浓度作为慢性支气管炎的一个标志物
N Engl J Med. 2017 Sep 7;377(10):911-922. doi: 10.1056/NEJMoa1701632.
10
Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts.慢性阻塞性肺疾病（COPD）亚型真的存在吗？10个独立队列中的COPD异质性与聚类分析
Thorax. 2017 Nov;72(11):998-1006. doi: 10.1136/thoraxjnl-2016-209846. Epub 2017 Jun 21.
Zotero 插件